| Bioactivity | Plasma kallikrein-IN-5 (Compound 20) is a potent covalent inhibitor of plasma potassium kinin peptide (Pka) with IC50 values of 66 nM and 70 pM at 1 minute and 24 hours, respectively. Plasma kallikrein-IN-5 can be used IN the study of hereditary angioedema (HAE)[1]. |
| Formula | C29H33BFN5O3 |
| Molar Mass | 529.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Allison M, et al. Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS Med Chem Lett. 2024 Mar 28;15(4):501-509. |
Plasma kallikrein-IN-5
CAS: F: C29H33BFN5O3 W: 529.41
Plasma kallikrein-IN-5 (Compound 20) is a potent covalent inhibitor of plasma potassium kinin peptide (Pka) with IC50 va
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.